ArticleProbiotics and antimicrobial proteins2025
Disruption of MRSA Biofilm and Virulence by Deep-Sea Probiotics: Impacts on Energy metabolism and Host Antimicrobial Peptides.
Article in Probiotics and antimicrobial proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Antibacterial and anti-virulence activity of the repurposed agent SX-682 against Staphylococcus aureus.BMC microbiology · 2026Article
- Antimicrobial peptide-induced inner membrane hyperpolarization is associated with antibiotic sensitization and attenuated MIC escalation in multidrug-resistant Gram-negative pathogens.npj antimicrobials and resistance · 2026Article
- Marine Bacteria as a Source of Antibiotics AgainstMarine drugs · 2026Review
- Topical Probiotics as a Novel Approach in the Treatment of Chronic Dermatoses Associated with Skin Dysbiosis: A Narrative Review.International journal of molecular sciences · 2025Review
- Structural and functional analysis of the accessory gene regulators of Staphylococcus aureus and Staphylococcus epidermidis: an in Silico approach.BMC microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat to public health due to its resistance to conventional antibiotics and its ability to form robust biofilms on both biotic and abiotic surfaces. In this study, we explore the novel mechanisms by which deep-sea-derived probiotics serve as an alternative strategy to combat MRSA infections. Three promising probiotic candidates, Lactococcus lactis (L25_4) and two strains of Leuconostoc pseudomesenteroides (L25_6 and L25_7), were isolated from ocean water collected at a depth of 312 m off the eastern coast of Taiwan. Each candidate strain demonstrated potent antimicrobial activity, significantly reducing MRSA biofilm formation when applied to pork skin. The strains also improved survival rates in a Galleria mellonella infection model (> 90% survival). Immunomodulatory effects were evident, with marked upregulation of Cecropin antimicrobial peptide (AMP) and downregulation of Gloverin AMP in the host. Scanning and transmission electron microscopy (SEM and TEM) revealed that probiotic treatments compromised MRSA cell membrane integrity, consistent with transcriptomic analysis showing downregulation of genes related to protein translation, membrane structure, and transporter systems. Collectively, our comprehensive in vitro, in vivo, ex vivo, and transcriptomic analyses reveal the intricate mechanisms by which deep-sea probiotics modulate both host and MRSA gene expression, underscoring their potential as innovative tools for addressing antibiotic-resistant infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.